GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Science Inc (XKRX:343090) » Definitions » Net Income From Continuing Operations

HLB Science (XKRX:343090) Net Income From Continuing Operations : ₩0.00 Mil (TTM As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is HLB Science Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. HLB Science's net income from continuing operations for the three months ended in . 20 was ₩0.00 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in . 20 was ₩0.00 Mil.


HLB Science Net Income From Continuing Operations Historical Data

The historical data trend for HLB Science's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Science Net Income From Continuing Operations Chart

HLB Science Annual Data
Trend Dec22 Dec23
Net Income From Continuing Operations
-5,052.53 -2,798.36

HLB Science Quarterly Data
Net Income From Continuing Operations

HLB Science Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in . 20 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HLB Science (XKRX:343090) Business Description

Industry
Traded in Other Exchanges
N/A
Address
66, Achasan-ro, 6th Floor, Seongdong-gu, Seoul, KOR
HLB Science Inc develops biological new drugs to treat infectious diseases. Its product pipelines includes DD-S052P, DD-A279, and DD-A514.

HLB Science (XKRX:343090) Headlines

No Headlines